O-Ray Pharma, Inc. specializes in the application of innovative drug delivery systems to the ear. Utilize the firm's proprietary delivery systems to deliver drugs directly to the cochlea for long periods of time, O-Ray has fashioned a novel approach to extended release drug delivery with implications for the treatment of a wide range hearing disorders. This technology platform already at work in other disciplines has lead to products approved by the NDA process of the FDA. O-Ray has an extensive library of patent rights to a variety of technologies, all the while continuing to build upon a foundation of preliminary data for proof of concept. O-Rays primary objective is to develop and test the use of these platforms in a range of drug classes. The goal is to subsequently license the technology to key partners through which continued trials and commercialization will be achieved.
